Vitali Grozman
Neck
Stockholm, AB, Sweden
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
The Stockholm Pilot study for Lung cancer Screening (Stockholm PLUS): feasibility of baseline low-dose CT lung cancer screening in a high-risk Swedish female population.
Journal: Acta oncologica (Stockholm, Sweden)
Published: September 23, 2025
Dose-Volume Predictors of Fatal Bronchopulmonary Bleeding After Stereotactic Body Radiation Therapy of Centrally Located Lung Tumors: An Analysis of the Expanded HILUS Cohort.
Journal: International journal of radiation oncology, biology, physics
Published: June 19, 2025
Germline MC1R Variant Status and Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Melanoma.
Journal: Pigment cell & melanoma research
Published: May 30, 2025
Stereotactic body radiation therapy for oligometastatic melanoma: a real-world study of the ESTRO/EORTC nomenclature.
Journal: Radiation oncology (London, England)
Published: May 10, 2025
Stereotactic body radiation therapy (SBRT) of centrally located medically inoperable early-stage non-small cell lung cancer (T1-T3N0M0) - A subgroup analysis of the expanded HILUS study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: December 19, 2024
Stereotactic body radiation therapy is beneficial for a subgroup of patients with urothelial cancer and solitary metastatic disease: a single institution real-world experience.
Journal: Radiation oncology (London, England)
Published: April 22, 2024
Diffusion weighted MRI and apparent diffusion coefficient as a prognostic biomarker in evaluating chemotherapy-antiangiogenic treated stage IV non-small cell lung cancer: A prospective, single-arm, open-label, clinical trial (BevMar).
Journal: European journal of radiology
Published: January 29, 2024
Radiotherapy with or without immunotherapy in metastatic melanoma: efficacy and tolerability.
Journal: Acta oncologica (Stockholm, Sweden)
Published: November 15, 2023
Expanded HILUS Trial: A Pooled Analysis of Risk Factors for Toxicity From Stereotactic Body Radiation Therapy of Central and Ultracentral Lung Tumors.
Journal: International journal of radiation oncology, biology, physics
Published: February 22, 2023
Dynamics of plasma thymidine kinase activity in metastatic melanoma reflects immune checkpoint inhibitor efficacy.
Journal: Acta oncologica (Stockholm, Sweden)
Published: September 09, 2022
Precision radiation of immune checkpoint therapy resistant melanoma metastases (PROMMEL study): study protocol for a phase II open-label multicenter trial.
Journal: Acta oncologica (Stockholm, Sweden)
Published: May 31, 2022
Plasma Thymidine Kinase Activity as a Novel Biomarker in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibitors.
Journal: Cancers
Published: December 15, 2021
Last Updated: 09/26/2026